Syneos Health (SYNH) Stock News, Apr-May 2020

Syneos Health (Nasdaq: SYNH) will have CEO Alistair Macdonald and CFO Jason Meggs present at the UBS Virtual Global Healthcare Conference on May 19, 2020, at 9:10 a.m. ET. The event aims to discuss strategies and performance in the biopharmaceutical sector. A live webcast of the presentation, along with supplementary materials and an archived audio replay, can be accessed via the company's Investor Relations website. Syneos Health operates as a fully integrated biopharmaceutical solutions organization, combining CRO and CCO capabilities to enhance customer performance globally.